Device Trial Radar · NCT05751278
Cryoprobe Versus Forceps for Transbronchial Biopsy
Last checked: Nov 20, 2026Latest source record: Apr 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
500
Actual
Start
Feb 27, 2023
Primary completion
Mar 2, 2026
Study completion Mar 2, 2026
Sponsor
- Lead sponsor
- Johns Hopkins UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Erbe USA Incorporated
- First posted
- Mar 2, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effectiveness of transbronchial biopsy done by a 1.1mm cryoprobe versus the standard 2.0mm forceps.
Conditions
- Lung Diseases
Interventions
ERBECRYO® 2 Cryosurgical Unit and Accessories - K190651Device
ERBE 1.1mm flexible single-use cryoprobe with oversheath
Radial Jaw 4 Pulmonary Biopsy ForcepsDevice
Radial Jaw 4 Pulmonary Biopsy Forceps Standard Capacity for 2mm endoscope
Primary outcomes
What the sponsor says the trial is designed to measure.
- Diagnostic yield as assessed by number of patients for which the procedure led to a diagnosisTime frame: During procedure, up to 1 hour
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Northwestern Medicine
Chicago, Illinois
University of Maryland, Baltimore (UMB)
Baltimore, Maryland
Johns Hopkins Hospital
Baltimore, Maryland
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.